Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Pregnancy termination in the 2nd trimester/Abortion Age: Adult |
Dose: Intramuscular – Initially, 250 mcg. Alternatively, initiate with test dose of 100 mcg Frequency: May be repeated at 1.5- to 3.5-hour intervals depending on uterine response Note: May be increased to 500 mcg if uterine contractility is inadequate. Maximum: 12 mg. Maximum duration: 2 days. |
|
Indication: Postpartum haemorrhage Age: Adult |
Dose: Intramuscular – Initially, 250 mcg by deep injection Frequency: May be repeated every 15-90-minutes Note: Maximum: 2 mg. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Form – Not established Note: Safety and efficacy not established |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Not specified Note: Renal impairment advises avoid. |
Administration
- For medical facility use only
- Give as directed by healthcare provider
Side Effect
- Nausea (1/3 patients)
- Vomiting (~2/3 patients)
- Diarrhea (~2/3 patients)
- Nervousness
- Epistaxis
- Sleep disorder
- Hyperthermia
- Flushing
- Asthma
- Wheezing
- Coughing
- Chest pain
- Hypertension
- Syncope
- Palpation
- Tachycardia
- Chest tightness
- Anxiety
- Chills/shivering
- Dizziness
- Drowsiness
- Dystonia
- Faintness
- Headache
- Lethargy
- Lightheadedness
- Vertigo
- Rash
- Breast tenderness
- Dysmenorrhea-like pain
- Hot flashes
- Dry throat
- Taste alterations
- Uterine bleeding (excessive)
- Local injection site pain
- Backache
- Leg cramps
- Muscular pain
- Parethesia
- Blurred vision
- Eye pain
- Eyelid twitching
- Tinnitus
- Bronchospasm
- Dyspnea
- Hiccups
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Other Oxytocics (Oxytocin, Methylergometrine)
|
May potentiate effect
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Acute Pelvic Inflammatory Disease
|
Risk of infection spread
|
|
Active Cardiac/Pulmonary Disease
|
Risk of organ complications
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.